Bartelt LA, Roche J, Kolling G, Bolick D, Noronha F, Naylor C, Hoffman P, Warren C, Singer S, Guerrant R. Persistent G. lamblia impairs growth in a murine malnutrition model. J Clin Invest. 2013;123:2672-84.
Bresee J, Hayden FG. Epidemic influenza–responding to the expected but unpredictable. N Engl J Med. 2013;368:589-92. doi: 10.1056/NEJMp1300375. Epub 2013 Jan 23.
Donowitz GR. Community-acquired pneumonia: 2012 history, mythology, and science. Trans Am Clin Climatol Assoc. 2013;124:283-93.
Eby JC, Gray MC, Warfel JM, Paddock CD, Jones TF, Day SR, Bowden J, Poulter MD, Donato GM, Merkel TJ, Hewlett EL. Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection. Infect Immun. 2013;81:1390-8 . doi: 10.1128/IAI.00110-13. Epub 2013 Feb 19
Guerrant RL, DeBoer MD, Moore SR, Scharf RJ, Lima AA. The impoverished gut–a triple burden of diarrhoea, stunting and chronic disease. Nat Rev Gastroenterol Hepatol. 2013;10:220-9. doi: 10.1038/nrgastro.2012.239. Epub 2012 Dec 11.
Korpe PS, Liu Y, Siddique A, Kabir M, Ralston K, Ma JZ, Haque R, Petri WA Jr. Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study. Clin Infect Dis. 2013;56:988-92. doi: 10.1093/cid/cis1044. Epub 2012 Dec 12.
Lewis JD, Bishop M, Heon B, Mathers AJ, Enfield KB, Sifri CD. Admission surveillance for carbapenamase-producing Enterobacteriaceae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2013;34:832-4. doi: 10.1086/671263. Epub 2013 Jun 27.
Mathers AJ, Hazen KC, Carroll J, Yeh AJ, Cox HL, Bonomo RA, Sifri CD. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the “menace” arrives in the new world. J Clin Microbiol. 2013;51:680-3. doi: 10.1128/JCM.02580-12. Epub 2012 Nov 21.
McManus KA, Engelhard CL, Dillingham R. Current challenges to the United States’ AIDS drug assistance program and possible implications of the Affordable Care Act. AIDS Research & Treatment. 2013(v. 2013):350169. http://dx.doi.org/10.1155/2013/350169.
Moreau GB, Mann BJ. Adherence and uptake of Francisella into host cells. Virulence. 2013;4:826-32. doi: 10.4161/viru.25629. Epub 2013 Jul 10.
Warren CA, van Opstal EJ, Riggins MS, Li Y, Moore JH, Kolling GL, Guerrant RL, Hoffman PS. Vancomycin treatment’s association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013;57:689-96. doi: 10.1128/AAC.00877-12. Epub 2012 Nov 12.
Selected Publications 2014 (January – June)
Asiimwe SB, Okello S, Moore CC. Frequency of vital signs monitoring and its association with mortality among adults with severe sepsis admitted to a general medical ward in Uganda. PLoS One. 2014;28;9:e89879. doi: 10.1371/journal.pone.0089879.
Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES. Pertussis pathogenesis–what we know and what we don’t know. J Infect Dis. 2014;209:982-5. doi: 10.1093/infdis/jit639.
Hoffman PS, Marshall AM, Olekhnovich I, Warren CA, Burgess SL, Hontecillas R, Viladomiu M, Bassaganya-Riera J, Guerrant RL, Macdonald TL. Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile Infections that also shows efficacy against Helicobacter pylori. Antimicrob Agents Chemother. 2014;58:4703-12. doi: 10.1128/AAC.03112-14. Epub 2014 Jun 2.
Liu J, Winstead-Derlega C, Houpt E, Heidkamp R, Pape J, Dillingham R. Pre-earthquake non-epidemic Vibrio cholerae in Haiti. J Infect Dev Ctries. 2014;8:120-2. doi: 10.3855/jidc.4524.
Madan R, Guo X, Naylor C, Buonomo EL, Mackay D, Noor Z, Concannon P, Scully KW, Pramoonjago P, Kolling GL, Warren CA, Duggal P, Petri WA Jr. Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infect Immun. 2014;82:341-9. doi: 10.1128/IAI.00972-13. Epub 2013 Oct 28.
Mathers AJ, Poulter M, Dirks D, Carroll J, Sifri CD, Hazen KC. Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol. 2014;35:350-5. doi: 10.1086/675603.
Moonah SN, Abhyankar MM, Haque R, Petri WA Jr. The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages. Infect Immun. 2014;82:3523-30. doi: 10.1128/IAI.01812-14. Epub 2014 May 12.
Musie E, Moore CC, Martin EN, Scheld WM. Toll-like receptor 4 stimulation before or after Streptococcus pneumoniae induced sepsis improves survival and is dependent on T-cells. PLoS One. 2014;9:e86015. doi: 10.1371/journal.pone.0086015.
Pérez NM, Ramakrishnan G. The reduced genome of the Francisella tularensis live vaccine strain (LVS) encodes two iron acquisition systems essential for optimal growth and virulence. PLoS One. 2014;9:e93558. doi: 10.1371/journal.pone.0093558.
Platts-Mills JA, Gratz J, Mduma E, Svensen E, Amour C, Liu J, Maro A, Saidi Q, Swai N, Kumburu H, McCormick BJ, Kibiki G, Houpt ER. Association between stool enteropathogen quantity and disease in Tanzanian children using TaqMan array cards: a nested case-control study. Am J Trop Med Hyg. 2014;90:133-8. doi: 10.4269/ajtmh.13-0439. Epub 2013 Nov 4.
Ralston KS, Solga MD, Mackey-Lawrence NM, Somlata, Bhattacharya A, Petri WA Jr. Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion. Nature. 2014;508:526-30. doi: 10.1038/nature13242. Epub 2014 Apr 9.
Reynolds J, Heysell SK. Understanding pharmacokinetics to improve tuberculosis treatment outcome. Expert Opin Drug Metab Toxicol. 2014;10:813-23. doi: 10.1517/17425255.2014.895813. Epub 2014 Mar 6.
Thomas TA, Heysell SK, Moodley P, Montreuil R, Ha X, Friedland G, Bamber SA, Moll AP, Gandhi N, Brant WE, Sturm W, Shah S. Intensified specimen collection to improve tuberculosis diagnosis in children from Rural South Africa, an observational study. BMC Infect Dis. 2014;14:11. doi: 10.1186/1471-2334-14-11. doi: 10.1186/1471-2334-14-11.
